Kim is a Senior Director and Distinguished Scientist at Genentech Inc. where she heads the Complex in vitro Systems (CiS) lab, a core group focused on employing new predictive tools to enhance clinical translational outcomes. She has prior experience holding key leadership positions in two biotech startups, one of which she co- founded while in graduate school at UT Austin. Prior to that, as a co- appointed postdoc at Roche and at the Wyss Institute in Harvard, Kim invented methods to bioprint human tissues and use them to model drug disposition, mode of action, and safety. She has ~50 peer reviewed publications and 16 patents and patent applications. Kim holds a B.S. degree in chemical engineering and Ph.D. in biomedical engineering; she is also a former United States Marine Corps officer and veteran.